Drug intelligence / Profile preview

microRNA-146a-5p mimic

Development stage
Preclinical
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Transfection
01

Overview

microRNA-146a-5p mimic is a synthetic double-stranded RNA oligonucleotide designed to simulate the biological activity of the endogenous tumor-suppressive microRNA, miR-146a-5p. In various malignancies, particularly epithelial ovarian cancer, miR-146a-5p expression is frequently downregulated, which contributes to apoptosis resistance and chemoresistance. The mimic functions by binding to the 3' untranslated regions (UTRs) of target mRNAs, leading to translational inhibition or mRNA degradation. Key therapeutic targets include anti-apoptotic genes such as XIAP, BCL2L2 (Bcl-w), and BIRC5 (Survivin). By suppressing these proteins, the mimic sensitizes cancer cells to DNA-damaging agents like cisplatin, thereby enhancing the efficacy of chemotherapy and promoting programmed cell death.

Other names
miR-146a-5p mimicmiR146a-5p mimicmiR 146a-5p mimichsa-miR-146a-5p mimichsa-miR146a-5p mimichsa-miR 146a-5p mimicmicroRNA-146a mimicmicroRNA146a mimicmicroRNA 146a mimic
02

Targets

BCL2L2 (BCL-2-like protein 2)X-linked inhibitor of apoptosis protein messenger RNA 3' untranslated regionBaculoviral IAP repeat-containing protein 5 messenger RNA 3' untranslated region

Beyond the preview

Go deeper on microRNA-146a-5p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-146a-5p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call